A quantitative approach to benefit-risk assessment of medicines – part 1: the development of a new model using multi-criteria decision analysis

2007129 citationsJournal Article

Authors

Stuart Walker · Micro Focus (United States)

Abstract

This novel approach based on MCDA has the potential for being applied as a new tool for judging and deciding on the benefits and risks, thereby helping regulators and industry in the development and approval of new medicines and their adequate use.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life Pharmacovigilance and Adverse Drug Reactions Statistical Methods in Clinical Trials

Publication Details

Published in: Pharmacoepidemiology and Drug Safety

Volume 16, Issue S1, pp. S2-S15

DOI: 10.1002/pds.1435

Field-Weighted Citation Impact: 14.58

Command Palette

A quantitative approach to benefit-risk assessment of medicines – part 1: the development of a new model using multi-criteria decision analysis

Authors

Abstract

Topics & Keywords

Publication Details